Balkin J, Zion M M, Rosenmann D, Ilan M, Klutstein M, Abraham A S
Department of Cardiology, Shaare Zedek Medical Center, Jerusalem, Israel.
Int J Card Imaging. 1993 Sep;9(3):213-7. doi: 10.1007/BF01145323.
The rate of progression of coronary artery stenoses (CAS) is not clear. Spontaneous regression may also occur. Seventy-one CAS in 25 patients who were enrolled in a study of the effects of chromium on CAS were analysed. Coronary angiography was performed in multiple views and patients randomised to chromium or placebo treatment. Videodensitometric quantitative analysis was performed using a Vanguard XR70 Analyzer. After 1 year all patients were recatheterised. Corresponding frames from identical views were analysed. CAS were assessed with the observers blinded to the initial study results. No differences were found between chromium or placebo and the results have been combined. There was no overall progression of CAS as assessed by % area stenosis (p = 0.65), % diameter stenosis (p = 0.19), stenotic area (p = 0.87), or stenotic diameter (p = 0.99). However, 20% of individual lesions progressed, while 10% regressed, and 70% remained the same. These changes must be taken into account in studies of interventions which may modify the course of coronary atherosclerosis, and if coronary by-pass surgery is to be performed with a 1 year delay after angiography.
冠状动脉狭窄(CAS)的进展速度尚不清楚。也可能会出现自发消退。对参与铬对CAS影响研究的25名患者的71处CAS进行了分析。采用多个视角进行冠状动脉造影,并将患者随机分为铬治疗组或安慰剂治疗组。使用Vanguard XR70分析仪进行视频密度定量分析。1年后,所有患者再次接受导管插入术。分析相同视角的相应帧。由对初始研究结果不知情的观察者评估CAS。铬治疗组和安慰剂治疗组之间未发现差异,因此将结果合并。通过狭窄面积百分比(p = 0.65)、狭窄直径百分比(p = 0.19)、狭窄面积(p = 0.87)或狭窄直径(p = 0.99)评估,CAS总体上没有进展。然而,20%的单个病变有进展,10%有消退,70%保持不变。在可能改变冠状动脉粥样硬化进程的干预研究中,以及如果在血管造影后1年延迟进行冠状动脉搭桥手术时,必须考虑这些变化。